| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6823679 | Schizophrenia Research | 2015 | 11 Pages |
Abstract
No large-scale patient registry has been conducted in the US to longitudinally follow patients with schizophrenia and describe symptom attributes, support network, care access and disease burden. These data provide important epidemiological, clinical and outcome insights into the burden of schizophrenia in the US.
Keywords
IRBWPAIsecond generation antipsychoticPersonal and Social PerformanceCGI-SCHfirst generation antipsychoticFGAPANSSDSM-IVIEQGEDSGAPSPCROPACSchizophreniastandard deviationdisease burdenChronic obstructive pulmonary diseaseCOPDRegistrykey informantDiagnostic and Statistical Manual of Mental Disorders, 4th editionContract research organizationbody mass indexBMIadverse eventFunctioningpositive and negative syndrome scalemosaicMINIMini International Neuropsychiatric Interviewinstitutional review boardDisease characteristicsWork Productivity and Activity Impairment
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Henry A. Nasrallah, Philip D. Harvey, Daniel Casey, Csilla T. Csoboth, James I. Hudson, Laura Julian, Ellen Lentz, Keith H. Nuechterlein, Diana O. Perkins, Nirali Kotowsky, Tracey G. Skale, Lonnie R. Snowden, Rajiv Tandon, Cenk Tek, Dawn Velligan,